ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

“Honor Roll” Of Top Investigators Who Won’t Be Funded Because Of Cuts

March 8, 1985

ASCO, NCCN Develop Quality Measures For Cancer Care

August 25, 2006

Budget Year

November 12, 2010

In Brief: INTRA-NCI Scramble For Funds involves “Tricks, Machinations, Day To Day Battle”

July 16, 1976

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

April 11, 2008

Cancer Congress Scientific Program To Update Basic, Clinical Science

April 2, 1982